Sight Sciences announced a Delaware District Court order upholding a jury verdict of willful patent infringement by Alcon, awarding damages and ongoing royalties.
Key takeaways
The U.S. District Court for the District of Delaware entered an order on March 27, 2026 preserving the jury's verdict that Alcon willfully infringed all three of Sight Sciences' asserted patents.
The court awarded $34 million in past monetary damages, plus supplemental damages and interest, plus a 10% ongoing royalty on Hydrus revenue through November 10, 2028.
The $34 million past damages consist of $5.5 million in lost profits and $28.5 million in royalty damages for Hydrus sales through the jury verdict date.
A final judgment is expected to be entered in the coming months after supplemental damages and pre-judgment interest are calculated, and is subject to appeal by Alcon.
Sight Sciences expects to record a $5.4 million success fee to operating expenses payable to its legal representation Cooley LLP.
Alcon's prior inter partes review petitions challenging two of the three asserted patents were denied by the USPTO in March 2023.